Figure 3. Comparison of the ELISA reactivity of rCatL, Peptide-1, SLbA and the EIE-LVC kit against sera from TL and VL patients and from L. infantum-infected dogs.

TL and VL: ELISAs were performed on samples from different groups of individuals (CT, control group; CD, Chagas disease patients; CL, cutaneous leishmaniasis; ML, mucosal leishmaniasis; VL, visceral leishmaniasis). CVL: ELISAs were performed on samples from different groups of dogs (CT, control group; CD, T. cruzi-infected dogs; CVL, canine visceral leishmaniasis). ^*Cut-off obtained by a ROC curve. ^#Cut-off suggested by the manufacturer.